Abeona Therapeutics Inc.
ABEO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000318306
In the last 90 days, Abeona Therapeutics Inc. insiders filed 0 open-market purchases and 10 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $243.3M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Abeona Therapeutics Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 37 | 40 | +3 |
| Shares | 9.39M | 12.5M | +3.08M (+32.8%) |
| Value | $37.9M | $52.5M | +$14.7M (+38.8%) |
New holders (9)
Institutions that held Abeona Therapeutics Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Schonfeld Strategic Advisors LLC | 153,930 | $648.0K | 0.01% |
| Susquehanna International Group, LLP | 68,877 | $290.0K | 0.00% |
| LPL Financial LLC | 24,450 | $102.9K | 0.00% |
| Creative Planning | 14,005 | $59.0K | 0.00% |
| Gsa Capital Partners LLP | 11,638 | $49.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 10,321 | $43.5K | 0.00% |
| Group One Trading, L.P. | 10,000 | $42.1K | 0.00% |
| Royal Bank of Canada | 7 | $0 | 0.00% |
| Highlander Capital Management, LLC | 1 | $0 | 0.00% |
Sold out (6)
Institutions that held Abeona Therapeutics Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 869,565 | $3.50M |
| Goldman Sachs Group Inc | 213,282 | $859.5K |
| Virtu Financial LLC | 32,171 | $130.0K |
| Deutsche Bank AG | 16,022 | $64.6K |
| FMR LLC | 16 | $64 |
| 25 LLC | 5 | $20 |